Koyfin Home > Directory > Health Care > Gilead Sciences Inc > EBITDA Margin

Gilead Sciences Inc EBITDA Margin Chart (GILD)

Gilead Sciences Inc annual/quarterly EBITDA Margin from 2010 to 2020. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Gilead Sciences Inc EBITDA Margin for the quarter ending September 09, 2020 was $54m a 28.85% increase of 15m year over year
  • Gilead Sciences Inc EBITDA Margin for the last 12 months ending September 09, 2020 was $27m a -5.47% decrease of -1m year over year
  • Gilead Sciences Inc Annual EBITDA Margin for 2019 was $29m a -63.32% decrease of -18m from 2018
  • Gilead Sciences Inc Annual EBITDA Margin for 2018 was $47m a -25.00% decrease of -12m from 2017
  • Gilead Sciences Inc Annual EBITDA Margin for 2017 was $59m a -7.16% decrease of -4m from 2016
Other Margins & Efficiency Metrics:
  • Gilead Sciences Inc Return on Capital % for the quarter ending December 12, 2018 was 5.53 a -87.56% decrease of -4.84 year over year
  • Gilead Sciences Inc Return on Equity % for the quarter ending December 12, 2018 was 0.05 a -55,717.16% decrease of -29.86 year over year
View Chart On Koyfin

Quarterly GILD EBITDA Margin Data

09/2020$54m
06/2020$37m
03/2020$50m
12/2019$38m
09/2019$51m
06/2019$52m
03/2019$49m
12/2018$40m
09/2018$53m
06/2018$47m

Annual GILD EBITDA Margin Data

2019$29m
2018$47m
2017$59m
2016$63m
2015$71m
2014$66m
2013$43m
2012$47m
2011$49m
2010$53m